Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

 Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada

Shots:

  • Nora collaborates with a biopharmaceutical partner to obtain the commercial rights for a biosimilar drug
  • The collaboration will support both private insurers and public formularies by reducing the costs of biosimilars & provide accessibility to patients for high quality affordable pharmaceutical products
  • Nora Pharma’s activities coordinate with the biosimilars transition policy adopted by several Canadian provinces

Click here to­ read full press release/ article | Ref: Newswire | Image: Stat News

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post